<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
		xmlns:xhtml="http://www.w3.org/1999/xhtml"
	>
<channel>
	<title>Beyond Single-Agent Checkpoint Blockade: Tuvonralimab&#8217;s Dual-Target Immunotherapy Approach to Overcoming Immune Resistance in Oncology へのコメント</title>
	<atom:link href="http://tblo.tennis365.net/35ww/2026/05/09/beyond-single-agent-checkpoint-blockade-tuvonralimabs-dual-target-immunotherapy-approach-to-overcoming-immune-resistance-in-oncology/feed/" rel="self" type="application/rss+xml" />
	<link>http://tblo.tennis365.net/35ww/2026/05/09/beyond-single-agent-checkpoint-blockade-tuvonralimabs-dual-target-immunotherapy-approach-to-overcoming-immune-resistance-in-oncology/</link>
	<description></description>
	<lastBuildDate>Mon, 10 Nov 2025 01:52:55 +0000</lastBuildDate>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
	<generator>http://wordpress.org/?v=3.5.1</generator>
</channel>
</rss>
